Benzinga | Oct 20, 2021 09:03AM EDT

RBC Capital Maintains Sector Perform on Enanta Pharmaceuticals, Raises Price Target to $74

RBC Capital analyst Brian Abrahams maintains Enanta Pharmaceuticals (NASDAQ:ENTA) with a Sector Perform and raises the price target from $58 to $74.